Toner Liam, Papa Nathan, Aliyu Sani H, Dev Harveer, Lawrentschuk Nathan, Al-Hayek Samih
Department of Surgery, Urology Unit, University of Melbourne, Melbourne, Australia.
Department of Microbiology, Addenbrookes' Hospital, Cambridge University, Cambridge, UK.
Investig Clin Urol. 2016 Mar;57(2):129-34. doi: 10.4111/icu.2016.57.2.129. Epub 2016 Mar 11.
Enterococci are a common cause of urinary tract infection and vancomycin-resistant strains are more difficult to treat. The purpose of this surveillance program was to assess the prevalence of and determine the risk factors for vancomycin resistance in adults among urinary isolates of Enterococcus sp. and to detail the antibiotic susceptibility profile, which can be used to guide empirical treatment.
From 2005 to 2014 we retrospectively reviewed 5,528 positive Enterococcus sp. urine cultures recorded in a computerized laboratory results database at a tertiary teaching hospital in Cambridge, United Kingdom.
Of these cultures, 542 (9.8%) were vancomycin resistant. No longitudinal trend was observed in the proportion of vancomycin-resistant strains over the course of the study. We observed emerging resistance to nitrofurantoin with rates climbing from near zero to 40%. Ampicillin resistance fluctuated between 50% and 90%. Low resistance was observed for linezolid and quinupristin/dalfopristin. Female sex and inpatient status were identified as risk factors for vancomycin resistance.
The incidence of vancomycin resistance among urinary isolates was stable over the last decade. Although resistance to nitrofurantoin has increased, it still serves as an appropriate first choice in uncomplicated urinary tract infection caused by vancomycin-resistant Enterococcus sp.
肠球菌是尿路感染的常见病因,耐万古霉素菌株更难治疗。本监测项目的目的是评估成年患者中肠球菌尿液分离株对万古霉素耐药的流行情况并确定其危险因素,详细描述抗生素敏感性谱,以指导经验性治疗。
2005年至2014年,我们对英国剑桥一家三级教学医院计算机化实验室结果数据库中记录的5528份阳性肠球菌尿液培养物进行了回顾性分析。
在这些培养物中,542份(9.8%)对万古霉素耐药。在研究过程中,未观察到耐万古霉素菌株比例的纵向变化趋势。我们观察到对呋喃妥因的耐药性呈上升趋势,耐药率从接近零攀升至40%。氨苄西林耐药率在50%至90%之间波动。利奈唑胺和奎奴普丁/达福普汀的耐药率较低。女性和住院状态被确定为万古霉素耐药的危险因素。
在过去十年中,尿液分离株中万古霉素耐药的发生率保持稳定。尽管对呋喃妥因的耐药性有所增加,但它仍是由耐万古霉素肠球菌引起的非复杂性尿路感染的合适首选药物。